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Abstract
Background: Sedation prior to esophagogastroduodenoscopy is widespread and increases patient comfort.
However, it demands additional trained personnel, accounts for up to 40 % of total endoscopy costs and impedes
rapid hospital discharge. Most patients lose at least one day of work. 98 % of all serious adverse events occurring
during esophagogastroduodenoscopy are ascribed to sedation. Acupuncture is reported to be effective as a
supportive intervention for gastrointestinal endoscopy, similar to conventional premedication. We investigated
whether acupuncture during elective diagnostic esophagogastroduodenoscopy could increase the comfort of
patients refusing systemic sedation.
Methods: We performed a single-center, double-blinded, placebo-controlled superiority trial to compare the
success rates of elective diagnostic esophagogastroduodenoscopies using real and placebo acupuncture. All
patients aged 18 years or older scheduled for elective, diagnostic esophagogastroduodenoscopy who refused
systemic sedation were eligible; 354 patients were randomized. The primary endpoint measure was the rate of
successful esophagogastroduodenoscopies. The intervention was real or placebo acupuncture before and during
esophagogastroduodenoscopy. Successful esophagogastroduodenoscopy was based on a composite score of
patient satisfaction with the procedure on a Likert scale as well as quality of examination, as assessed by the
examiner.
Results: From February 2010 to July 2012, 678 patients were screened; 354 were included in the study. Baseline
characteristics of the two groups showed a similar distribution in all but one parameter: more current smokers
were allocated to the placebo group. The intention-to-treat analysis included 177 randomized patients in each
group. Endoscopy could successfully be performed in 130 patients (73.5 %) in the real acupuncture group and
129 patients (72.9 %) in the placebo group. Willingness to repeat the procedure under the same conditions was
86.9 % in the real acupuncture group and 87.6 % in the placebo acupuncture group.
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Conclusions: Esophagogastroduodenoscopy without sedation is safe and can successfully be performed in
two-thirds of patients. Patients planned for elective esophagogastroduodenoscopy without sedation do not
benefit from acupuncture of the Sinarteria respondens (Rs) 24 Chengjiang middle line, Pericard (Pc) 6 Neiguan
bilateral, or Dickdarm (IC) 4 Hegu bilateral, according to traditional Chinese medicine meridian theory.
Trial registration: DRKS00000164. Registered on 10 December 2009.
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Background
More than 10 million upper gastrointestinal endoscopic
procedures are performed in the United States annually
[1, 2], and more than 2.8 million in Germany [3]. The
standard use of systemic sedation to facilitate the per-
formance of esophagogastroduodenoscopy and increase
patient comfort has contributed to the widespread use
and acceptance of this procedure. However, the per-
ceived benefits of improved patient comfort and satisfac-
tion afforded by parenteral sedation must be measured
against the increased risk of adverse cardiopulmonary
events and higher attendant costs [4].
Complications arising from esophagogastroduodeno-
scopy are usually associated with the use of systemic
sedation and the dose given. More than 60 % of all
adverse events [5] and more than 98 % of all serious
adverse events in upper gastrointestinal endoscopy are
ascribed to systemic sedation [6]. In 2008, the first S3-
guidelines for sedation to improve patient safety in
gastrointestinal endoscopy in Germany were published
[7]. Besides other considerations, sedation demands add-
itional trained personnel. Therefore, it is estimated that
sedation and related issues account for up to 40 % of
total endoscopy costs, including overhead and indirect
costs [8, 9]. Specifically, an additional specialized nurse
or physician is required to perform and monitor sys-
temic sedation.
Furthermore, systemic sedation impedes rapid hospital
discharge, causing patients to miss work. Following eso-
phagogastroduodenoscopy, the individual may feel well
and often believes that he or she has no functional im-
pairment. In contrast, studies of psychomotor effects
show that the effects of systemic sedation can extend for
3 to 12 hours from the end of the procedure until
patients have recovered clinically [10], and most patients
lose at least one day of work [11].
Moreover, especially in the early postoperative period,
surgical patients often have impaired gastric function
and duodenogastroesophageal reflux, resulting in de-
layed gastric emptying [12]. Therefore, conscious sed-
ation is often not possible or has high complication rates
in these patients, owing to the risk of aspiration.
Acupuncture has been used as a part of traditional
Chinese medicine for more than 2000 years [13]. Many
studies have investigated the benefits and success of acu-
puncture in reducing pain for various acute and chronic
diseases. However, most of them had methodological dif-
ficulties, e.g. the inclusion of an adequate control group
[14]. A Cochrane review from 2009 on acupuncture for
migraine prophylaxis reported that even acupuncture at
the wrong place (sham acupuncture) could have a sig-
nificant effect on the primary endpoint measure [15].
Therefore, the use of a real placebo needle seems to be a
better alternative to overcome this problem. With the
introduction of such a placebo acupuncture needle sys-
tem some years ago, a new and valid instrument to
measure placebo effects has become available [16].
If the use of acupuncture could improve examination
quality and tolerance of diagnostic esophagogastroduo-
denoscopy without sedation, it should be possible to
increase the willingness of patients to undergo this
examination without systemic sedation. Consequently, it
would be possible to reduce the rate of serious adverse
events due to systemic sedation and to lower the
personnel and material costs. In 2004, a review article
concluded that acupuncture seems to be effective as a
supportive intervention for gastrointestinal endoscopy,
providing similar tolerability to that of conventional pre-
medication but superior tolerability to that of sham acu-
puncture [17].
To date, only one double-blind controlled trial of
patients undergoing esophagogastroduodenoscopy has
been performed [18]. The study, reported in 1978, used
real versus sham acupuncture (1 cm away from the acu-
puncture point), with 10 needles and electrical stimula-
tion, in 90 patients and showed that upper endoscopy
was much easier and better tolerated after real acupunc-
ture. However, this study lacked a clearly defined
primary endpoint measure and a detailed sample size
calculation and had the disadvantage of using sham
acupuncture instead of a real placebo acupuncture
technique in the control group. Two additional, par-
tially randomized studies have methodological limita-
tions [19, 20]. An adequately designed, controlled
clinical trial with a well-defined primary endpoint
measure and detailed sample size calculation has not
yet been conducted. Therefore, the objective of this
trial was to compare the ability of real versus placebo
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acupuncture to improve tolerance of diagnostic eso-
phagogastroduodenoscopy in patients not receiving
intravenous sedation.
Methods
The ACUPEND trial was designed as single-center,
double-blinded, randomized superiority trial with a one-
by-one allocation ratio into two parallel treatment arms.
The study protocol was registered (Germanctr.de:
DRKS00000164) and published in advance to ensure the
transparency of the trial design and analysis procedures,
after approval of the protocol by the Ethics Committee
of the University of Heidelberg [21]. The trial was con-
ducted in accordance with the 1989 Declaration of
Helsinki [22] and the principles of Good Clinical Prac-
tice at the Interdisciplinary Center for Endoscopy of the
University of Heidelberg. The study protocol was
designed according to the Standards for reporting Inter-
ventions in Clinical Trials of Acupuncture (STRICTA)
[23]. The statistical design and analysis were performed
independently at the Institute of Medical Biometry and
Informatics of the University of Heidelberg. There were
no changes or amendments to the trial protocol
throughout the study.
Participants
All patients scheduled for elective diagnostic esophago-
gastroduodenoscopy in the Interdisciplinary Center for
Endoscopy of the University of Heidelberg were
screened and informed about the trial in detail by a trial
investigator before their informed consent was re-
quested. All patients older than 18 years and scheduled
for an elective diagnostic esophagogastroduodenoscopy
who refused systemic sedation were considered for par-
ticipation. The exclusion criteria were refusal to partici-
pate, ASA score V, participation in another trial that
could interfere with the primary endpoint, impaired
mental state, expected lack of compliance, need for sys-
temic sedation, emergency procedures, pregnancy, and
known allergy to lidocaine anesthetic spray or acupunc-
ture needle material.
Randomization and intervention
To achieve comparable groups for known and unknown
risk factors, randomization was performed using block
randomization in a 1:1 allocation ratio. The random allo-
cation sequence was generated by the Institute of Med-
ical Biometry and Informatics with SAS version 9.1
(PROC PLAN). Treatment group allocation was per-
formed using sealed and consecutively numbered
opaque envelopes produced by the Institute of Medical
Biometry and Informatics.
Patients were randomly sorted into groups after provid-
ing the investigator with informed consent; afterwards, the
investigator performed the placebo or real acupuncture
according to the randomization result.
Patients were prepared by staff nurses for the esopha-
gogastroduodenoscopy as usual. A study nurse or inves-
tigator was present to monitor and document all
procedures. All patients were positioned on a stretcher
lying on their backs in a 30° reverse Trendelenburg pos-
ition. Oxygen saturation and blood pressure were moni-
tored by standard, non-invasive means. Staff personnel
provided pharyngeal anesthesia using a topical xylocaine
spray (AstraZeneca, Germany) for all patients. Before
the endoscopic procedure was performed, the acupunc-
turist opened the allocation envelope. The physician
performing the esophagogastroduodenoscopy and the
assistant nurse were not informed of the allocation and
entered the examination room after the acupuncture
procedure was finished. Therefore, patients and exam-
iners were both blinded to the trial intervention.
Only physicians with experience of at least 30 acu-
puncture procedures performed the study treatments.
For further support, and to minimize any treatment bias,
an acupuncture point search device (Silberbauer PS 3,
Austria) was used.
Control group: placebo acupuncture
All control group patients received placebo acupuncture
at the following points according to the Streitberger pla-
cebo acupuncture needle system procedure: Sinarteria
respondens (Rs) 24 Chengjiang middle line to reduce
choking [24], Pericardium (Pc) 6 Neiguan bilateral to re-
duce gastroenteral motility [25] and large intestine (IC)
4 Hegu bilateral to reduce nausea and vomiting [26]
(Fig. 1).
After localizing the correct acupuncture point, sup-
ported by the search device, a synthetic ring (9 mm
external diameter, 4 mm internal diameter, 3 mm
height; Asiamed company, Munich, Germany) was
fixed by a patch on the skin just above the selected
point. Through this patched ring, a 32G placebo nee-
dle (No. PL, 30 × 0.3 mm stainless steel needle from
the Asiamed company) was inserted for half to one
inch. Because of the telescopic effect and the blunt
tip of the placebo needle, an impression of penetra-
tion for the patient was imitated. All needles were
placed and left in position for 5 min prior to and
throughout the endoscopic procedure (Fig. 2).
Experimental group: real acupuncture
After being prepared as described above, experimental
group patients received a real acupuncture in accord-
ance with the traditional Chinese medicine median the-
ory at the following acupuncture points: Sinarteria
respondens (Rs) 24 Chengjiang middle line to reduce
choking, Pericardium (Pc) 6 Neiguan bilateral to reduce
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gastroenteral motility and large intestine (IC) 4 Hegu
bilateral to reduce nausea and vomiting.
After localizing the correct acupuncture point sup-
ported by the search device, a synthetic ring (9 mm
external diameter, 4 mm internal diameter, 3 mm
height; Asiamed company) was fixed by a patch on
the skin just above the selected point. Through this
patched ring a 32G verum needle (No. 016 Special,
30 × 0.3 mm stainless steel needle from the Asiamed
company) was inserted for half to one inch (Fig. 3).
All needles were placed and left in position for
5 min prior to and throughout the endoscopic
procedure.
Both procedures lasted about 10 min, comparable to
the time needed to prepare patients for a systemic
sedation.
Outcomes
The main endpoint measure was the frequency of suc-
cessfully performed esophagogastroduodenoscopy as a
function of the randomized intervention.
Successful esophagogastroduodenoscopy was defined
in accordance with the definition of Abraham et al. [27]
as a composite score of patient satisfaction, with the
procedure assessed on a Likert scale (from 1 = acceptable
to 5 = unacceptable), and quality of examination, as
assessed by the examiner. Each anatomic area (esopha-
gus, stomach, duodenum up to the second stage, and
proximal stomach viewed in retro flexion) that was ad-
equately viewed received a score of 1, while area that were
inadequately viewed were scored 0; this produced a max-
imum score of 4 if all anatomic areas could be well visual-
ized. An esophagogastroduodenoscopy was counted as
successfully performed if the patient’s satisfaction was
rated 1 or 2 on the Likert scale and the examination qual-
ity score was 4/4 [27–30].
Fig. 1 Placebo needle system
Fig. 2 Cross-section of placed 32G placebo needle with synthetic
ring and patch
Fig. 3 Real acupuncture: 32G needle in place with synthetic ring
and patch
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The primary endpoint measure was assessed immedi-
ately after the elective diagnostic esophagogastroduode-
noscopy was completed; the results of quality of
examination were documented in a case report form
with tick boxes by the physician who performed the
examination. The patients were asked by a study nurse
to rate their satisfaction with the examination after the
completion of esophagogastroduodenoscopy, prior to
being told the results of their procedure and prior to dis-
charge from the recovery room.
Secondary endpoint measures were willingness to re-
peat the procedure, defined as readiness of the patient to
repeat the examination under the same conditions; heart
rate (beats per minute); blood pressure (mmHg), and
oxygen saturation (percent) assessed before esophago-
gastroduodenoscopy, after passage of the larynx, and
after removal of the endoscope; the duration of the
examination (min) from insertion to removal of the
endoscope; and all peri-interventional complications as
described and defined in the protocol publication.
Sample size calculation
The sample size calculation was based on the two-sided
chi-square test for difference with respect to the primary
endpoint. A review of the literature identified a random-
ized controlled trial from Abraham et al. with a group of
419 patients, which compared the rate of successful eso-
phagogastroduodenoscopy with and without sedation
[27]. In both groups, pharyngeal anesthesia was per-
formed. This trial showed a successful examination rate
of 46 % in the group without sedation. A successful
examination was defined as a composite score of patient
satisfaction with the procedure and quality of the exam-
ination, as assessed by the endoscopist. For our trial, we
adopted the same endpoint definition to facilitate using
the 46 % success frequency of the non-sedated group as
the baseline for our sample size calculation. We believe
that an increase of the success frequency by 15 %, or to
≥61 %, in the real acupuncture group would be clinically
relevant and therefore could have a significant impact
on clinical practice. To detect this difference with a type
I error rate of 0.05 (two-sided) with 80 % power, a sam-
ple size of 173 evaluable patients per group was neces-
sary (SAS 9.1 PROC POWER). The drop-out rate within
the intervention was expected to be about 2 % overall.
Therefore, the total number of patients needed to be
randomized was 354.
Statistical analysis
Confirmatory analysis
The null hypothesis was assessed by testing the inter-
vention effect in a primary analysis using a two-sided
chi-square test. In a secondary analysis, a binary logistic
regression model that took into account the covariates
‘intervention’ (placebo or acupuncture), age (<65 or ≥65),
sex, and smoking status (yes or no) was used. A two-sided
type I error rate of 0.05 was applied to the primary and
secondary analysis. Confirmatory analysis was primarily
based on the full analysis set, which is consistent with the
intention-to-treat principle, by including all patients who
were randomized into the two groups. This approach re-
flects the idea that the study should correspond to the
conditions in clinical practice as closely as possible.
The secondary variables were analyzed in a descriptive
manner by tabulating the measures of the empiric distri-
butions. According to the scale level of the variables,
means, standard deviations, medians, first and third
quartiles, and minimum and maximum or absolute and
relative frequencies, respectively, are reported. Descrip-
tive values of P for the corresponding statistical tests
comparing the treatment groups and associated 95 %
confidence intervals are given.
The homogeneity of the treatment groups was demon-
strated descriptively using the demographic data and
baseline values. All statistical analyses were performed
using SAS® software, Version 9.1 (or higher) of the SAS
System for Unix (SAS Institute Inc., Cary, NC, USA).
Results
Patient enrollment
Out of 678 patients screened between February 2010
and July 2012, 354 were included (Fig. 4). The baseline
characteristics of the two groups are listed in Table 1.
Most of the evaluated parameters showed a similar dis-
tribution between both groups. Only the current smok-
ing status was distributed unevenly. More current
smokers were allocated to the placebo group.
Primary endpoint measure
The intention-to-treat analysis included 177 randomized
patients in each group. Endoscopy could be performed
successfully according to the definition by Abraham et
al. [27] in 130 patients (73.5 %) in the real acupuncture
group and in 129 patients (72.9 %) in the placebo group.
No significant difference could be detected in univariate
analysis with the chi-square test (P = 0.9045) or in the
multivariate logistic regression model (odds ratio 0.929;
95 % confidence interval, 0.574–1.504). Only age showed
a small significant difference favoring a successful endos-
copy (odds ratio 1.023; 95 % confidence interval, 1.005–
1.041) (Table 2).
Secondary endpoint measures
The median duration of endoscopy was 7 min in both
groups with a range of 2–20 min in the real acupuncture
and 2–25 min in the placebo group (P = 0.406). Intraven-
ous sedation was necessary in one patient in each group
(P = 1). An acupuncture point search device was used in
Schaible et al. Trials  (2016) 17:350 Page 5 of 9
all but four (2.3 %) patients in the real acupuncture
group and in all but two (1.1 %) patients in the placebo
acupuncture group. Heart rate, blood pressure, and oxy-
gen saturation showed no significant differences between
the treatment groups at the beginning of the procedure,
after passage of the larynx, or after removal of the endo-
scope. The gagging reflex was reduced in 98 (55.7 %)
patients of the real acupuncture group and 94 (53.1 %)
patients of the placebo acupuncture group (P = 0.627). A
characteristic sensation due to manipulation of the
Fig. 4 CONSORT Flowchart. ITT intention-to-treat; PP per-protocol
Table 1 Baseline characteristics (intention-to-treat)
Characteristic Placebo acupuncture group (n = 177) Real acupuncture group (n = 177) P
Sex (%) Female 63 (35.6) 55 (31.1) 0.367a
Age (years) Mean (± standard deviation) 53.4 (13.8) 52.3 (13.5) 0.422b
Body mass index (kg/m2) Mean (± standard deviation) 26.7 (6.5) 25.8 (4.9) 0.139b
Current chemotherapy (%) Yes 3 (1.7) 5 (2.8) 0.474a
Current smoking (%) Yes 38 (21.5) 22 (12.4) 0.023a
ASA score (%) I 32 (18.1) 30 (16.9) 0.768
II 106 (59.9) 110 (62.1)
III 36 (20.3) 36 (20.3)
IV 3 (1.7) 1 (0.6)
ASA American Society of Anesthesiology: Physical Status Classification System
P ≤ 0.05
aChi squared test
bt test
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penetrating needle (De Qi = sensation along the channel)
was reported by 68 (38.6 %) patients in the real acu-
puncture group and 26 (14.7 %) patients in the placebo
acupuncture group (P = 0.001). After completing the
procedure, 153 (86.9 %) patients in the real acupuncture
group and 155 (87.6 %) patients in the placebo acupunc-
ture group were willing to repeat the procedure under
the same conditions (P = 0.857).
No significant differences in peri-interventional com-
plication frequencies were found between the interven-
tion groups (Table 3).
Discussion
The German sedation guideline states that sedation
must be offered for every gastrointestinal endoscopy.
However, standard use of systemic sedation during diag-
nostic esophagogastroduodenoscopy is responsible for
nearly all severe complications of esophagogastroduo-
denoscopy [6] and for at least 40 % of the direct
costs of the procedure [8]. In addition, indirect costs
arise from patients losing a minimum of one day of
work, so that significant economic advantages would
accrue if the time of impairment could be shortened
or eliminated [11].
Furthermore, patients who had an abdominal oper-
ation within a few days prior to esophagogastroduo-
denoscopy have an increased risk for delayed gastric
empting and therefore an increased risk for aspiration
during esophagogastroduodenoscopy, especially if sed-
ation is given. Therefore, systemic sedation for these
patients is often not possible, and general anesthesia
is necessary if a procedure without sedation is not
feasible. Therefore, it would be beneficial to have an
effective alternative to systemic sedation.
A 2004 review of acupuncture in the context of gastro-
intestinal endoscopy concludes that acupuncture seems
to be effective as a supportive intervention for gastro-
intestinal endoscopy, with outcomes similar to those of
conventional premedication [17]. Concerning acupunc-
ture during esophagogastroduodenoscopy, few studies
have been published: one double-blind, controlled
trial performed in 1978 and two partially randomized
studies with methodological limitations in 1999 and
2002 [19, 20]. The randomized, controlled trial using
real versus sham acupuncture (1 cm away from the
acupuncture point) showed that upper endoscopy was
much easier and better tolerated after real acupuncture
[18]. However, a Cochrane review on acupuncture for
migraine prophylaxis from 2009 reports that even acu-
puncture at the wrong place (sham acupuncture) can have
a significant effect on the primary endpoint [15].
In our study, we decided to use Streitberger’s placebo
needle system for the control group, simulating real acu-
puncture, instead of sham acupuncture, to avoid the
necessity of penetrating of the skin [16]. In other trials,
control groups have received obviously different treat-
ments, and no attempt was made to evaluate the cred-
ibility of the placebo used, so that psychological factors
might be largely responsible for differences between
groups [31]. Streitberger et al. validated the placebo nee-
dle system successfully in two randomized controlled
trials [16, 32]. The De Qi sensation sign was significantly
different in our trial between intervention groups, but
other trials have reported that the De Qi sign alone is
not a valid predictor for the impact of the acupuncture
effect [33].
In our study, we found no difference between the
two acupuncture groups regarding successful esopha-
gogastroduodenoscopy rate; our successful esophago-
gastroduodenoscopy rate was 73 % in both groups
and thus nearly as high that of the sedation group
(76 %) in Abraham’s study [27]. One possible inter-
pretation of these results would be that the placebo
Table 2 Multivariate logistic regression analysis of primary
endpoint measure
Parameter Odds ratio 95 % confidence interval P
Intervention 0.929 0.574–1.504 0.7641
Smoking 0.933 0.498–1.747 0.8278
Age (years) 1.023 1.005–1.041 0.0114
Body mass index (kg/m2) 1.035 0.990–1.082 0.1324
Table 3 Frequency of peri-interventional complications
Parameter Real acupuncture group Placebo acupuncture group Total P
Hematoma 4 (2.3 %) 0 (0 %) 4 (1.1 %) 0.044
Bleeding 4 (2.3 %) 0 (0 %) 4 (1.1 %) 0.044
Nerve irritation 1 (0.6 %) 0 (0 %) 1 (0.3 %) 0.317
Bradycardia 1 (0.6 %) 0 (0 %) 1 (0.3 %) 0.317
Hypotension 1 (0.6 %) 0 (0 %) 1 (0.3 %) 0.317
Low oxygen saturation 1 (0.6 %) 0 (0 %) 1 (0.3 %) 0.317
Aspiration 0 (0 %) 0 (0 %) 0 (0 %) –
Wound infection 0 (0 %) 0 (0 %) 0 (0 %) –
Schaible et al. Trials  (2016) 17:350 Page 7 of 9
needle system had the same effects as real acupunc-
ture, because a small acupressure effect might have
been induced by the method. Therefore, we decided
that another control group without acupuncture
would be necessary to clarify this problem. After
approval of this planned prospective cohort study by
the Ethics Committee of the University of Heidelberg,
we included another 100 consecutive patients with
the same inclusion and exclusion criteria as the ACU-
PEND trial. The rate of successful elective esophago-
gastroduodenoscopy was evaluated in this group in
exactly the same manner as described in this paper.
This group without acupuncture had a 68 % successful
esophagogastroduodenoscopy frequency, and therefore
no significant difference in esophagogastroduodenoscopy
success compared with the real or placebo acupuncture
groups. Therefore, we assume that, in our study, neither
real nor placebo acupuncture affected successful eso-
phagogastroduodenoscopy frequency. However, a po-
tential weakness of the present study is that this
control group without acupuncture was not primarily
planned in the study as a third arm, and patients
were not randomized.
The willingness to repeat the procedure under the
same conditions was 86.9 % versus 87.6 % in the real
versus placebo acupuncture group. This rate is even
higher than that of the sedated group in Abraham’s
study (81 %) and much higher than in Abraham’s non-
sedated group (61 %). Surprisingly, the highest willing-
ness to repeat was in our non-sedated control group
(94 %) [27]. This is even more astonishing, as all of our
physicians performed our esophagogastroduodenosco-
pies; we did not exclude beginners. The difference in
willingness might be due to cultural and social influ-
ences as important modifiers of patient satisfaction
[26]. Waye noted the prevalent use of sedation in
America (72 %) compared with Europe (56 %) and
Asia (44 %) [34].
No evidence can be obtained in this trial concerning
the specificity of acupuncture points; this requires
another study where groups with different acupuncture
points should be compared.
Conclusions
Esophagogastroduodenoscopy without sedation is safe
and can successfully be performed in two-thirds of
patients.
Patients planned for elective esophagogastroduodeno-
scopy without sedation do not benefit from acupuncture
of Sinarteria respondens (Rs) 24 Chengjiang middle line,
Pericard (Pc) 6 Neiguan bilateral, and Dickdarm (IC) 4
Hegu bilateral, according to the traditional Chinese
medicine meridian theory.
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